Regulatory T-cell directed therapies in liver diseases

Journal of Hepatology

Volumn 59, Issue 5, 2013, Pages 1127-1134

  Oo, Ye Htun ^a   Sakaguchi, Shimon ^b,c  

^a University Hospital Birmingham NHS Foundation Trust   (United Kingdom)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Autoimmune hepatitis; Cell therapy; Liver cancer; Regulatory T cell; Transplantation

Indexed keywords

AUTOANTIGEN; BASILIXIMAB; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CYTOCHROME P450 2D6; DACLIZUMAB; DENILEUKIN DIFTITOX; GUANOSINE PHOSPHATE; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 6 ANTIBODY; RAPAMYCIN; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; VITAMIN D;

ADOPTIVE TRANSFER; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CYTOKINE RELEASE; END STAGE LIVER DISEASE; GENE TRANSFER; GENETIC MANIPULATION; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STELLATE CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS HEPATITIS;

AUTOIMMUNE HEPATITIS; CELL THERAPY; LIVER CANCER; REGULATORY T CELL; TRANSPLANTATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HEPATITIS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOMODULATION; LIVER DISEASES; LIVER NEOPLASMS; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 84885954601     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.05.034     Document Type: Note

References (60)

1. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 2005 345 352
2. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
3. N. Ohkura, M. Hamaguchi, H. Morikawa, K. Sugimura, A. Tanaka, and Y. Ito T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development Immunity 37 2012 785 799
4. D.H. Adams, and B. Eksteen Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease Nat Rev Immunol 6 2006 244 251
5. Y.H. Oo, C.J. Weston, P.F. Lalor, S.M. Curbishley, D.R. Withers, and G.M. Reynolds Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver J Immunol 184 2010 2886 2898
6. S. Norris, C. Collins, D.G. Doherty, F. Smith, G. McEntee, and O. Traynor Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes J Hepatol 28 1998 84 90
7. M. Heydtmann, D. Hardie, P.L. Shields, J. Faint, C.D. Buckley, and J.J. Campbell Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes J Immunol 177 2006 729 738
8. H.X. Wei, Y.H. Chuang, B. Li, H. Wei, R. Sun, and Y. Moritoki CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice J Immunol 181 2008 7221 7229
9. G. Mieli-Vergani, and D. Vergani Autoimmune hepatitis Nat Rev Gastroenterol Hepatol 8 2011 320 329
10. Y.H. Oo, S.G. Hubscher, and D.H. Adams Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management Hepatol Int 4 2010 475 493
11. J. Shimizu, S. Yamazaki, and S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity J Immunol 163 1999 5211 5218
12. J. Fu, D. Xu, Z. Liu, M. Shi, P. Zhao, and B. Fu Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 132 2007 2328 2339
13. T. Boettler, H.C. Spangenberg, C. Neumann-Haefelin, E. Panther, S. Urbani, and C. Ferrari T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection J Virol 79 2005 7860 7867
14. O. Franzese, P.T. Kennedy, A.J. Gehring, J. Gotto, R. Williams, and M.K. Maini Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection J Virol 79 2005 3322 3328
15. D. Saadoun, M. Rosenzwajg, F. Joly, A. Six, F. Carrat, and V. Thibault Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis N Engl J Med 365 2011 2067 2077
16. L. Lu, K. Ikizawa, D. Hu, M.B. Werneck, K.W. Wucherpfennig, and H. Cantor Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway Immunity 26 2007 593 604
17. B. Zhang, T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells J Exp Med 186 1997 1677 1687
18. F.E. Lund, and T.D. Randall Effector and regulatory B cells: modulators of CD4(+) T cell immunity Nat Rev Immunol 10 2010 236 247
19. H. Hadeiba, T. Sato, A. Habtezion, C. Oderup, J. Pan, and E.C. Butcher CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease Nat Immunol 9 2008 1253 1260
20. M.S. Longhi, Y. Ma, D.P. Bogdanos, P. Cheeseman, G. Mieli-Vergani, and D. Vergani Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease J Hepatol 41 2004 31 37
21. M.S. Longhi, Y. Ma, R.R. Mitry, D.P. Bogdanos, M. Heneghan, and P. Cheeseman Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis J Autoimmun 25 2005 63 71
22. M.S. Longhi, M.J. Hussain, R.R. Mitry, S.K. Arora, G. Mieli-Vergani, and D. Vergani Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis J Immunol 176 2006 4484 4491
23. M.A. Kriegel, T. Lohmann, C. Gabler, N. Blank, J.R. Kalden, and H.M. Lorenz Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II J Exp Med 199 2004 1285 1291
24. M.S. Longhi, M.J. Hussain, W.W. Kwok, G. Mieli-Vergani, Y. Ma, and D. Vergani Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis Hepatology 53 2011 536 547
25. A. Schneider, M. Rieck, S. Sanda, C. Pihoker, C. Greenbaum, and J.H. Buckner The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells J Immunol 181 2008 7350 7355
26. R.K. Venigalla, T. Tretter, S. Krienke, R. Max, V. Eckstein, and N. Blank Reduced CD4+, CD25- T cell sensitivity to the suppressive function of CD4+, CD25high, CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus Arthritis Rheum 58 2008 2120 2130
27. R. Liberal, C.R. Grant, B.S. Holder, Y. Ma, G. Mieli-Vergani, and D. Vergani The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway Hepatology 56 2012 677 686
28. S.M. Curbishley, B. Eksteen, R.P. Gladue, P. Lalor, and D.H. Adams CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow Am J Pathol 167 2005 887 899
29. Y.H. Oo, V. Banz, D. Kavanagh, E. Liaskou, D.R. Withers, and E. Humphreys CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver J Hepatol 57 2012 1044 1051
30. O. Boyman, and J. Sprent The role of interleukin-2 during homeostasis and activation of the immune system Nat Rev Immunol 12 2012 180 190
31. S. Letourneau, E.M. van Leeuwen, C. Krieg, C. Martin, G. Pantaleo, and J. Sprent IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25 Proc Natl Acad Sci U S A 107 2010 2171 2176
32. L. Stross, J. Gunther, G. Gasteiger, T. Asen, S. Graf, and M. Aichler Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice Hepatology 56 2012 873 883
33. K.J. Chen, S.Z. Lin, L. Zhou, H.Y. Xie, W.H. Zhou, and A. Taki-Eldin Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis PLoS One 6 2011 e24671
34. P. Yang, Q.J. Li, Y. Feng, Y. Zhang, G.J. Markowitz, and S. Ning TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma Cancer Cell 22 2012 291 303
35. A.J. Rech, R. Mick, S. Martin, A. Recio, N.A. Aqui, and D.J. Powell Jr. CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients Sci Transl Med 4 2012 134ra162
36. J. Dannull, Z. Su, D. Rizzieri, B.K. Yang, D. Coleman, and D. Yancey Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells J Clin Invest 115 2005 3623 3633
37. S. Telang, M.A. Rasku, A.L. Clem, K. Carter, A.C. Klarer, and W.R. Badger Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma BMC Cancer 11 2011 515
38. R.P. Sutmuller, L.M. van Duivenvoorde, A. van Elsas, T.N. Schumacher, M.E. Wildenberg, and J.P. Allison Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses J Exp Med 194 2001 823 832
39. G.Q. Phan, J.S. Weber, and V.K. Sondak CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues Ann Surg Oncol 15 2008 3014 3021
40. M. Lopez, M.R. Clarkson, M. Albin, M.H. Sayegh, and N. Najafian A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells J Am Soc Nephrol 17 2006 2844 2853
41. L. Strauss, T.L. Whiteside, A. Knights, C. Bergmann, A. Knuth, and A. Zippelius Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin J Immunol 178 2007 320 329
42. P. Sagoo, N. Ali, G. Garg, F.O. Nestle, R.I. Lechler, and G. Lombardi Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells Sci Transl Med 3 2011 83ra42
43. A. Demirkiran, A. Kok, J. Kwekkeboom, J.G. Kusters, H.J. Metselaar, and H.W. Tilanus Low circulating regulatory T-cell levels after acute rejection in liver transplantation Liver Transpl 12 2006 277 284
44. A. Demirkiran, C.C. Baan, A. Kok, H.J. Metselaar, H.W. Tilanus, and L.J. van der Laan Intrahepatic detection of FOXP3 gene expression after liver transplantation using minimally invasive aspiration biopsy Transplantation 83 2007 819 823
45. P. Lapierre, K. Beland, R. Yang, and F. Alvarez Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance Hepatology 57 2013 217 227
46. M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing, and A. Niwa Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor Immunity 30 2009 899 911
47. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, and M. Oukka Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
48. J. Zhao, and S. Perlman Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-gamma, IL-2 and IL-2R PLoS One 7 2012 e46241
49. M. Dominguez-Villar, C.M. Baecher-Allan, and D.A. Hafler Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease Nat Med 17 2011 673 675
50. M.A. Koch, G. Tucker-Heard, N.R. Perdue, J.R. Killebrew, K.B. Urdahl, and D.J. Campbell The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation Nat Immunol 10 2009 595 602
51. X. Zhou, N. Kong, J. Wang, H. Fan, H. Zou, and D. Horwitz Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu J Immunol 185 2010 2675 2679
52. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775 787
53. F. Baeke, H. Korf, L. Overbergh, A. Verstuyf, L. Thorrez, and L. Van Lommel The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation J Immunol 186 2011 132 142
54. L.E. Jeffery, F. Burke, M. Mura, Y. Zheng, O.S. Qureshi, and M. Hewison 1,25-Dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3 J Immunol 183 2009 5458 5467
55. J.K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe, and U. Baron DNA methylation controls Foxp3 gene expression Eur J Immunol 38 2008 1654 1663
56. A. Erhardt, C. Wegscheid, B. Claass, A. Carambia, J. Herkel, and H.W. Mittrucker CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis J Immunol 186 2011 5284 5293
57. A.K. Abbas, C. Benoist, J.A. Bluestone, D.J. Campbell, S. Ghosh, and S. Hori Regulatory T cells: recommendations to simplify the nomenclature Nat Immunol 14 2013 307 308
58. J.Y. Tsang, Y. Tanriver, S. Jiang, S.A. Xue, K. Ratnasothy, and D. Chen Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice J Clin Invest 118 2008 3619 3628
59. C. Scotta, M. Esposito, H. Fazekasova, G. Fanelli, F.C. Edozie, and N. Ali Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4+CD25+FOXP3+ Treg subpopulations Haematologica 2012
60. T.N. Golovina, T. Mikheeva, T.M. Brusko, B.R. Blazar, J.A. Bluestone, and J.L. Riley Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells PLoS One 6 2011 e15868